Aristotle University Of Thessaloniki (AUTH)
Μελέτη της δράσης αντιμυκητιακών φαρμάκων έναντι βιοϋμενίων μη ασπεργιλλικών υφομυκήτων
Abstract
dc:descriptionBackground: Scedosporium and Fusarium species, as well as Mucormycetes, are emerging opportunistic pathogens, causing invasive fungal diseases in humans, particularly inimmunocompromised patients. Biofilm-related infections are associated with increased morbidity and mortality. Here, we assessed the ability of Scedosporium apiospermum, Fusarium solani species complex (FSSC) and Lichtheimia Corymbifera isolates to form biofilms and evaluated the efficacy of deoxycholate amphotericin B (DAMB), liposomal amphotericin B (LAMB), and voriconazole (VRC) or Posaconazole (POS), alone or in combination, against mature biofilms. We also examined the effects of deoxycholate and liposomal amphotericin B (DAMB, LAMB) and voriconazole on antifungal activities and immune responses of neutrophils (PMNs) against mature biofilms compared with their planktonic counterparts. Methods: Biofilm formation was assessed by safranin staining and spectrophotometric measurement of optical density. Planktonic and biofilm damage was assessed by XTT reduction assay. Planktonic cell and biofilm MIC50s were determined as the minimum concentrations that caused ≥50% fungal damage compared to untreated controls. The combined activity of L-AMB and VRC or POS against biofilms was determined by the checkerboard microdilution method and analyzed by the Bliss independence model. Antifungal activity of human PMNs exposed to mature biofilms and planktonic cells alone or combined with DAMB, LAMB and VRC/POS was assessed as fungal damage by XTT assay. Cytokine production was evaluated by multiplex ELISA, following PMN stimulation with biofilms in the presence/absence of each drug. Results: All organisms showed similar profiles of susceptibility to the 3 drugs, resulting in biofilms resistance to azoles studied. Synergistic effects were observed at certain concentrations of L-AMB combined to VRC or POS against S. apiospermum or L.corymbiferabiofilms. Antagonistic interactions were found when LAMB combined with VRC against FSSC isolates. All drugs showed additive or synergistic effects with PMNs against S. apiospermum. The same additive or synergistic effect was also found for DAMB and POS with PMNs against L.corymbifera biofilms. However, antagonism was shown primarily against FSSC. IncreasedIL-8 was produced by PMNs exposed to S. apiospermum biofilms plus DAMB or VRC compared with PMNs exposed to biofilms alone. LAMB and VRC caused similar IL-10 levels with those released by biofilm-exposed PMNs. Conclusions: DAMB and LAMB were more efficacious against biofilms of the 3 studied fungal pathogens. We showed for the first time that the combination of L-AMB and VRC/POS produces synergy against Scedosporium and Lichtheimia biofilms, but antagonism against Fusarium biofilms in specific drug concentration ranges. These results may be the basis for further understanding the antifungal susceptibility of biofilms of these difficult-to-treat organisms and the interactions of antifungal agents frequently used against them. The synergistic, additive or antagonistic effects of DAMB, LAMB or VRC/POS on biofilm-exposed PMNs are organism-specific, with FSSC exhibiting greater resilience than S. apiospermum or L.Corymbifera to antifungals. Biofilms of both Scedosporium and Fusarium caused dampened immune responses. The drug-mediated immunomodulating effect on PMNs, evidenced byIL-1β, enhanced host protective functions. There is still much to be deciphered about the potential interplay between antifungal agents, fungal biofilms and phagocytes. So far, limited clinical data exist to assess the benefits of immunomodulatory therapy.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vikelouda, Aikaterini
- Βικελούδα, Αικατερίνη
Subjects
dc:subject × 17- Βιοϋμένια
- Υφομύκητες
- Έλεγχος ευαισθησίας στα αντιμυκητιακά
- Αλληλεπίδραση φαρμάκων
- Πολυμορφοπύρηνα ουδετερόφιλα
- Κυτταροκίνες
- Biofilms
- Hyphomycetes
- Antifungal susceptibility testing
- Neutrophils
- Cytokines
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Λοιμώδη νοσήματα
- Health Sciences
- Medical and Health Sciences
- Infectious Diseases
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54226